Results 241 to 250 of about 2,471,823 (311)

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country. [PDF]

PLoS One
Do TX, Nguyen HT, Nguyen PTL, Kieu MTT, Duong TV, Pham VNH.   +5 more
europepmc   +1 more source

Introducing AI & Innovation

AI &Innovation, EarlyView.
Mirko Farina, Xiao Yu, Rongrong Ji, Chen Jin, Vincent Blok, Paolo Ciancarini, Ngcaweni Busani, Witold Pedrycz   +7 more
wiley   +1 more source

Maximizing public health benefits: Policy perspectives on coverage and cell-based influenza vaccines in the US. [PDF]

Hum Vaccin Immunother
Nguyen VH, Mould-Quevedo JF.
europepmc   +1 more source

One size does not fit all: income-sensitive thresholds for catastrophic health expenditure. [PDF]

Health Policy Plan
Dubey JD, Kumar D, Reddy A B.
europepmc   +1 more source

Reasons for hesitancy and acceptance of COVID-19 vaccination among the Congolese population: a scoping review. [PDF]

Front Health Serv
Lobukulu Lolimo G, Khonde R, Matondo H, Kabele J, Musawu K Y, Beshah SA, Achala DM, Njeri Muriithi G, Adote ENA, Zegeye EA, Mbachu CO, Ataguba JE, Yaya Bocoum FIK, Manitu SM.   +13 more
europepmc   +1 more source

Public Sector Economics

, 2017
openaire   +1 more source

Air Ambulance Contracting and Reimbursement and the No Surprises Act.

JAMA Netw Open
Duffy E, Ly B, Trish E.
europepmc   +1 more source

II SUMMER SCHOOL IN PUBLIC ECONOMICS: Economics of Taxation & Political Economy [PDF]

Pilar Sorribas-Navarro, Pilar Sorribas-Navarro   +1 more
core